- Home
- MREO vs VALU Comparison
MREO vs VALU Comparison
Compare MREO & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | VALU |
|---|---|---|
| Founded | 2015 | 1931 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 340.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | VALU |
|---|---|---|
| Price | $2.02 | $38.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.20 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 2.6K |
| Earning Date | 11-10-2025 | 12-15-2025 |
| Dividend Yield | N/A | ★ 3.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.26 |
| Revenue | $500,000.00 | ★ $34,516,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $131.12 | N/A |
| P/E Ratio | ★ N/A | $17.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.47 | $32.94 |
| 52 Week High | $3.88 | $55.01 |
Technical Indicators
Market Signals| Indicator | MREO | VALU |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 60.15 |
| Support Level | $1.89 | $37.55 |
| Resistance Level | $2.37 | $39.30 |
| Average True Range (ATR) | 0.17 | 0.99 |
| MACD | -0.01 | 0.25 |
| Stochastic Oscillator | 40.48 | 83.72 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.